[{"title": "Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy", "link": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12134768/", "details": "I Asfour, S Karim, SA Tabraiz, A Chahal, MY Khanji\u2026 - Annals of Noninvasive \u2026, 2025", "abstract": "Background Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is a well\u2010established indicator of myocardial fibrosis in hypertrophic cardiomyopathy (HCM). However, its association with \u2026"}, {"title": "QRICH1 regulates ATF6 transcription to affect pathological cardiac hypertrophy progression", "link": "https://link.springer.com/article/10.1186/s10020-025-01241-2", "details": "L Zhang, H Chen, G Zou, W Jia, H Dong, C Wang\u2026 - Molecular Medicine, 2025", "abstract": "Many studies have shown that pathological cardiac hypertrophy is associated with active endoplasmic reticulum (ER) stress. Glutamine-rich protein 1 (QRICH1), as a transcriptional regulator, belongs to the caspase recruitment domain (CARD) \u2026"}, {"title": "Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank", "link": "https://cardiab.biomedcentral.com/articles/10.1186/s12933-025-02788-4", "details": "A Bertrand, X Zhou, A Lewis, T Monfeuga, R Gupta\u2026 - Cardiovascular Diabetology, 2025", "abstract": "Cardiometabolic disturbances play a central role in the pathogenesis of heart failure with preserved ejection fraction (HFpEF). Due to its complexity, HFpEF is a challenging condition to treat, making phenotype-specific disease management a \u2026"}, {"title": "Circular Tale of Micropeptides in Cardiac Hypertrophy", "link": "https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.125.326368", "details": "T Pedrazzini - Circulation Research, 2025", "abstract": "Cardiomyocytes exit the cell cycle shortly after birth and quickly become terminally differentiated. The adult mammalian heart has, therefore, limited regenerative capacity to replace lost muscle after injury. Instead, cardiomyocytes compensate \u2026"}, {"title": "External validation of atrial fibrillation risk prediction tools in a racially diverse cohort of hypertrophic cardiomyopathy patients", "link": "https://www.sciencedirect.com/science/article/pii/S1547527125025068", "details": "H Pronovost, AA Kassamali, J Ehmsen, B Rivers\u2026 - Heart Rhythm, 2025", "abstract": "Background Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with hypertrophic cardiomyopathy (HCM). The 2024 AHA/ACC guidelines recommend validated clinical tools such as the HCM-AF score for individualized \u2026"}, {"title": "Predictive Value of Left Ventricular Systolic Dysfunction or Wall Motion Abnormalities for Non-Ischemic Myocardial Injury: A Multicenter Cardiovascular Resonance \u2026", "link": "https://www.mdpi.com/2077-0383/14/11/3691", "details": "JM Sokolska, J Rajewska-Tabor, M Kozi\u0144ski\u2026 - Journal of Clinical Medicine, 2025", "abstract": "Background: Left ventricle (LV) systolic dysfunction, defined as a global (LVejection fraction, LVEF< 50%) and/or regional wall motion abnormalities (RWMA), are the major parameters assessed in patients with cardiovascular diseases. The study \u2026"}, {"title": "Management of Recurrent Idiopathic Ventricular Fibrillation: A Case Report from Diagnosis to Succesful Ablation", "link": "https://academic.oup.com/ehjcr/advance-article-pdf/doi/10.1093/ehjcr/ytaf247/63212468/ytaf247.pdf", "details": "J Adamek, O Jiravsky, I Ranic, J Chovancik, J Kautzner - European Heart Journal \u2026, 2025", "abstract": "Background Idiopathic ventricular fibrillation (IVF) is a rare cause of sudden cardiac death and is a diagnosis of exclusion. With the availability of genetic testing, this condition is becoming increasingly rare. Nevertheless, in some cases, no identifiable \u2026"}]
